Co-Founder and Chief Technology Officer
Philip Lee is Co-Founder and Chief Technology Officer for Senti Bio, leading Technical Operations and Manufacturing for the Company’s “smarter” medicines. He is an entrepreneur and technology platform builder, with over 15 years of experience leading innovative technical and business teams. Prior to joining Senti Bio, Dr. Lee held various positions at MilliporeSigma, a division of Merck KGaA, including as the Head of Cell Culture Systems. Dr. Lee was Co-Founder and CEO of CellASIC Corp., a pioneer in microfluidic cell culture systems which was later acquired by Merck KGaA.
Dr. Lee earned his B.S. in Chemical Engineering and Biology from Massachusetts Institute of Technology and his Ph.D. in Bioengineering from the University of California, Berkeley and the University of California, San Francisco.